FDC Ltd (FDC) — shareholding pattern, promoter holding, financials and share price

About FDC Ltd (FDC)

FDC Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as FDC and on the BSE under scrip code 531599. Its ISIN is INE258B01022.

FDC (Fairdeal Corporation) Ltd Limited (found in 1936) is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialized formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Some of FDC’s leading brands in India include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zathrin, Zipod, Cotaryl and Mycoderm in the domestic and international markets. [1]

FDC Limited is a leading pharmaceutical company in India, engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs). It is particularly noted for its expertise in oral rehydration solutions, energy drinks, antibiotics, and ophthalmic therapies.

The company has expanded its global footprint through two wholly-owned subsidiaries in the USA and UK, and a joint venture in South Africa. FDC is also setting up advanced manufacturing plants to enhance its production capabilities.

Listed peers in Pharmaceuticals: Sanofi India Ltd, Jeena Sikho Lifecare Ltd, Supriya Lifescience Ltd, Senores Pharmaceuticals Ltd, Aarti Pharmalabs Ltd, Innova Captab Ltd.

Valuation & Returns

10 Jul 2026

At ₹430.45 a share on 10 Jul 2026, FDC Ltd (FDC) was valued at a price-to-earnings ratio of 24.9x and a price-to-book of 3.07x on a book value of ₹140.11 per share as of Mar 2025. Solomo computes return on equity of 12.34% and return on capital employed of 16.49% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
24.9x
P/B
3.07x
EPS (TTM)
₹17.29
Book value / share
₹140.11
ROE
12.34%
ROCE
16.49%
ROA
10.37%
Debt / equity
0.01x
Dividend yield
1.16%
EBITDA margin
28.27%
52-week range
₹3,057.6 – ₹6,025.45

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, FDC Ltd (FDC) reported revenue of ₹2,171 crore, net profit of ₹281 crore and earnings per share of ₹17.29. That compares with revenue of ₹2,108 crore and net profit of ₹267 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹585 crore and net profit ₹103 crore (consolidated).

Consolidated annual results for FDC Ltd (FDC), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)1,5251,7841,9432,1082,171
Net profit (₹ cr)216194305267281
EPS (₹)12.8211.718.7516.3917.29
Compound annual growth for FDC Ltd (FDC). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth8.30%9.23%10.87%8.50%
Profit growth5.51%2.09%7.60%-12.55%
Stock price CAGR8%2%8%-15%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 69.66% of FDC Ltd (FDC) (unchanged from the previous quarter), foreign institutional investors (FII) hold 1.4% and domestic institutional investors (DII) hold 6.31%. Market capitalisation was ₹7,008 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.

Largest disclosed public shareholders in Jun 2026: ICICI PRUDENTIAL SMALLCAP FUND 2.8%, NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND 2.63%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202669.66%-1.4%6.31%30.34%
Mar 202669.66%-2.4%6.29%30.34%
Dec 202569.66%-2.32%6.27%30.34%
Sep 202569.66%-2.43%6.82%30.34%
Jun 202569.66%-2.41%7.17%30.34%
Mar 202569.66%-2.55%6.37%30.34%
Dec 202469.66%-2.67%6.08%30.34%
Sep 202469.66%-2.62%6.03%30.34%
Every quarter since Mar 2001 Filing data, not investment advice.